Authors: MARSHALL JL WELLSTEIN A RAE J DELAP RJ PHIPPS K HANFELT J YUNMBAM MK SUN JX DUCHIN KL HAWKINS MJ

Citation: Jl. Marshall et al., PHASE-I TRIAL OF ORALLY-ADMINISTERED PENTOSAN POLYSULFATE IN PATIENTSWITH ADVANCED CANCER, Clinical cancer research, 3(12), 1997, pp. 2347-2354

Authors: ZHOU XJ SQUIRES K PANZHOU XR BERNHARD S AGROFOGLIO L KIRK M DUCHIN KL SOMMADOSSI JP

Citation: Xj. Zhou et al., PHASE-I DOSE-ESCALATION PHARMACOKINETICS OF AZT-P-DDI (IVX-E-59) IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Journal of clinical pharmacology, 37(3), 1997, pp. 201-213

Authors: BUICE RG SUBRAMANIAN VS DUCHIN KL UKONNE S

Citation: Rg. Buice et al., BIOEQUIVALENCE OF A HIGHLY VARIABLE DRUG - AN EXPERIENCE WITH NADOLOL, Pharmaceutical research, 13(7), 1996, pp. 1109-1115

Authors: ZHOU XJ SQUIRES K BERNHARD S DELOACH L DUCHIN KL SOMMADOSSI JP

Citation: Xj. Zhou et al., DOSE-ESCALATING PHARMACOKINETICS OF AZT-P-DDI (IVX-E-59) AFTER SHORT-TERM INTRAVENOUS-INFUSION AND ORAL-ADMINISTRATION IN HIV-INFECTED PATIENTS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 103-103

Authors: GEHR TWB SICA DA GRASELA DM DUCHIN KL

Citation: Twb. Gehr et al., THE PHARMACOKINETICS AND PHARMACODYNAMICS OF FOSINOPRIL IN HEMODIALYSIS-PATIENTS, European Journal of Clinical Pharmacology, 45(5), 1993, pp. 431-436